Fate Therapeutics, Inc. (FATE)
NASDAQ · Manufacturing · Biological products, (no diagnostic substances)
$2.35+$0.0200 (+0.86%) on the dayAs of the close; data may be delayed.
FATE price, last 12 months
Key stats
- Previous close
- $2.33
- Open
- $2.34
- Day range
- $2.27 – $2.47
- 52-week range
- $0.9500 – $3.23
- Volume
- 3.4M
- Avg volume (20 days)
- 1.5M
- Market cap
- $281.6M
Performance
1W−7.1%
1M−8.6%
3M+11.9%
6M+91.1%
YTD+139.2%
1Y+132.7%
vs S&P 500, 1Y+115.9 pts
Technicals and fundamentals
About Fate Therapeutics, Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
- Sector
- Manufacturing
- Industry
- Biological products, (no diagnostic substances)
- Listed on
- NASDAQ
- Market cap
- $281.6M